AIP
EMN icon

Arrowpoint Investment Partners’s Eastman Chemical EMN Stock Holding History

Arrowpoint Investment Partners’s Portfolio EMN Stock Details EMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,493
Closed -$228K – 1031
2024
Q4 		$228K Buy
+2,493
New +$256K 0.05% 354

Other funds holding EMN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Arrowpoint Investment Partners's EMN Position: Q1 2025 in Review

Arrowpoint Investment Partners sold out of Eastman Chemical (EMN) in Q1 2025, closing a stake of 2,493 shares — an estimated $228K sold.

Arrowpoint Investment Partners first reported a position in EMN in Q4 2024 and held it in 1 quarter. The position peaked at $228K in Q4 2024. 806 funds tracked by Wall St. Rank hold EMN as of Q1 2025.

  • Arrowpoint Investment Partners reported no remaining Eastman Chemical position as of Q1 2025 after selling out during the quarter.
  • Arrowpoint Investment Partners sold 2,493 Eastman Chemical shares in Q1 2025, an estimated $228K.
  • Arrowpoint Investment Partners first reported a position in Eastman Chemical in Q4 2024 and held it in 1 quarter.
  • Arrowpoint Investment Partners's Eastman Chemical position peaked at $228K in Q4 2024.
  • 806 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2025.

Based on Arrowpoint Investment Partners's 13F filing for Q1 2025, filed 13 May 2025.